RxDoctor Payments Data

Bogdan Protyniak, MD

Colon & Rectal Surgery · Wilkes-Barre, PANPI 1154632388

Payments from drug & device makers

What this record shows

This record is dominated by education: $346,852 of the $428,554 with a category attached, or 80.9%. Intuitive Surgical accounts for 99.1% of it on its own, with 11 other manufacturers making up the rest. Among colon & rectal surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$428,554in general payments, 2019–2025

Across 461 payments — averaging $929.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$425K
  • Medtronic$1K
  • Johnson & Johnson$744
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$500
  • Axonics, Inc.$329
  • Davol Inc.$324
  • plus $600 from 6 others

What the payments were for

  • Consulting fees$6360%
  • Speaking & faculty fees$41,69510%
  • Travel & lodging$18,7354%
  • Food & beverage$20,5815%
  • Education$346,85281%
  • Gifts$550%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$428,554 in reported general payments places this provider in the 95th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$122,353
Medicare patients
238
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate28$125
Oxycodone Hcl25$93
Metronidazole31$67
Ondansetron Hcl26$36

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Wilkes-Barre

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →